Orphan Reach is extremely honoured to be part of this crucial Phase II COVID-19 trial at the forefront of clinical research. We are delighted to be […]
Orphan Reach today confirmed that they have been acquired by Emmes, a global, full-service CRO dedicated to supporting the advancement of public health and biopharmaceutical innovation. […]
There are some changes in the data protection law, so we wanted you to know that we've updated our Privacy Policy. Your trust is important to us, and we want to make sure you understand what these changes mean for you.
Please visit our Privacy Policy page for more information about our Privacy and Cookie Policy.